Why Is Windtree Therapeutics (WINT) Stock Up 116% Today?

Windtree Therapeutics (NASDAQ:WINT) stock is rocketing higher on Friday after the biotechnology company provided an update on its clinical trial of istaroxime. Additionally, Windtree Therapeutics is gearing up for a study of istaroxime to treat SCAI Stage C cardiogenic shock patients. These are more ill than those with SCAI Stage B early cardiogenic shock. WINT Stock Movement on Friday Investors will want to keep reading for more of the most recent stock market news today! On Penny Stocks and Low-Volume Sto ...